Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Compositions for colon cleansing and treatment of gastrointestinal disorders

A pharmacy, allylglycine technology, applied in the direction of drug combination, drug delivery, medical preparations containing active ingredients, etc., can solve the problems of low adenoma detection, long operation time, short examination interval and so on

Pending Publication Date: 2022-07-08
硬木药品公司
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Inadequate bowel preparation may lead to lower adenoma detection, longer operative time, and shorter intervals between examinations

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Compositions for colon cleansing and treatment of gastrointestinal disorders
  • Compositions for colon cleansing and treatment of gastrointestinal disorders
  • Compositions for colon cleansing and treatment of gastrointestinal disorders

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0589] Example 1: cGMP accumulation in T84 cells for analysis of GC-C activity

[0590] For cGMP assays, 2.0x10 5 Cells / mL of T84 cells were grown overnight in 96-well tissue culture plates. The next day, T84 cells were washed twice with 200 μL DMEM+20 mM MES (pH 5) or DMEM+50 mM sodium bicarbonate (pH 8) or DMEM pH 7 without additives. These buffers do not contain serum. After the second wash, cells were incubated with 180 μL of 1 mM isobutylmethylxanthine (IBMX) in buffer pH 5, 7 or 8 for 10 minutes at 37° C. to inhibit any phosphodiesterase activity. The peptides were then diluted to 10-fold concentration in pH 5, 7 or 8 buffer. Dilute 20 μL of the peptide solution to a final volume of 200 μL with T84 cells to make each peptide concentration 1×. Eleven point curve analysis was performed for each peptide and final peptide concentrations in nM were tested in each assay: 10000, 3000, 1000, 300, 100, 30, 10, 3, 1, 0.3, 0.1.

[0591] There is no peptide control used to de...

Embodiment 2

[0596] Example 2: GC-C binding assay

[0597] All GC-C bindings were performed in a final volume of 200 μL of media pH 5, 7 or 8. Medium was prepared at pH 5 using DMEM and 0.5% BSA and 20 mM 2-(N-morpholino)ethanesulfonic acid (MES). Medium was prepared at pH 7 using DMEM and 0.5% BSA. Medium was prepared at pH 8 using DMEM and 0.5% BSA containing 20 mM sodium bicarbonate.

[0598] T84 cells were used at a rate of 250,000 cells per reaction. Cells were grown to confluence on T-150 flasks using DMEM-F12 50 / 50 medium with 5 mM L-glutamine and 5% FBS. Cells were scraped using DMEM and 0.5% BSA and counted to determine how much volume to add per reaction to give 250,000 cells in a final volume of 200 μL. Reactions were then started at 200,000 CPM per reaction of I125-STp, cold peptide competitor, and T84 cells in sequence. The samples were then incubated at 37°C for 1 hour. After 1 hour, all samples were added to pre-blocked GF-C plates and aspirated through. Each well w...

Embodiment 3

[0599] Example 3: In vitro metabolic incubation of rat intestinal fluid (RIF)

[0600] Rat intestinal fluid was obtained by adding PBS to ligated rat jejunal loops for 30 minutes. Intestinal fluid was then collected, pooled and kept on ice before centrifugation at 4°C. The supernatant was removed and snap frozen. 60 [mu]M peptide (100 [mu]g / mL) was then added to rat intestinal fluid along with PBS and 0.5% BSA. Control incubations were performed in PBS. 50 μL aliquots were then taken in duplicate from all samples at 0, 10, 30 and 60 minutes and stopped with 12% trichloroacetic acid containing internal standard.

[0601] The samples were spun and the supernatant removed for analysis by LC-MS using the calculated exact mass of each peptide (or predicted metabolite) to generate an extracted ion chromatogram. The relative response factor (analyte peak area / internal standard peak area) for each sample was used to construct the percent remaining relative to time=0. Results fo...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention provides peptides and compositions useful in the treatment of gastrointestinal disorders or for colon cleansing. The invention also provides compositions and methods for treating gastrointestinal disorders and pharmaceutical compositions for implementing the same. In some embodiments, the pharmaceutical compositions include oral dosage forms.

Description

[0001] This application is a divisional application of an invention patent application with an application date of April 29, 2016, an application number of 201680032088.2, and an invention title of "composition for colon cleansing and treatment of gastrointestinal disorders". [0002] This application claims priority under 35 USC § 119(e) to US Provisional Patent Application Serial No. 62 / 156,077, filed May 1, 2015, the entire contents of which are hereby incorporated by reference. [0003] This application incorporates by reference in its entirety the Sequence Listing entitled "IW154PCT1Sequence_ST25.txt" (45.1 kilobytes), which was created on April 28, 2016 and filed together in electronic form. technical field [0004] The present invention relates to peptides, compositions and methods for colon cleansing and treatment of disorders of the gastrointestinal tract and other internal organs. Background technique [0005] About 15 million colonoscopies are performed each year ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07K7/08
CPCC07K7/08A61K38/00A61K9/0031A61P1/10A61P35/00A61K38/10A61K38/12A61K9/0053A61K45/06
Inventor M.G.卡里R.索林加C.莱泰泽
Owner 硬木药品公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com